Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for Exercise Induced Blood Flow in T2DM
NCT01779596Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2011
- Primary completion
- Dec 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bosentan in type 2 diabetes mellitus (T2DM), sponsored by Radboud University Medical Center. Started May 2011; status: completed.
02
Drugs
bosentan
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01779596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779596.